4th Quarter - Report
POLICY ADVOCATES for GLAXOSMITHKLINE
Firm
Client
Income
$20,000
Expenses
—
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
Tax reform legislation
| Lobbyist | Covered position, as disclosed |
|---|---|
| VICTOR CABRAL | — |
| JACK MARTIN | — |
Copyright/Patent/Trademark CPT
S. 1720 Patent Transparency and Improvemnets Act S. 1612 Patent Litigation Integrity Act S. 1013 Patent Abuse Reduction Act S 866 Patent Quality Improvement ActHR 3309 Patent Inovation Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| VICTOR CABRAL | — |
| JACK MARTIN | — |
Health Issues HCR
HR 3204-Drug Quality and Security Act HR 3742-Antibiotic Development Patient Treamnet Act HR 1248-Family Health Care Flexibility Act HR 2725-FDA Safety ovr Sequestration Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| VICTOR CABRAL | — |
| JACK MARTIN | — |
Budget/Appropriations BUD
Agriculture Approps FDA Funding
| Lobbyist | Covered position, as disclosed |
|---|---|
| VICTOR CABRAL | — |
| JACK MARTIN | — |
Trade (domestic/foreign) TRD
TPA, TPP, TTIP trade issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| VICTOR CABRAL | — |
| JACK MARTIN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.